349 related articles for article (PubMed ID: 15907530)
1. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
Liu CZ; Huang HY; Tsai PJ; Shih MH
Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530
[TBL] [Abstract][Full Text] [Related]
2. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
Liu CZ; Hur BT; Huang TF
Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor.
Fitzgerald JR; Loughman A; Keane F; Brennan M; Knobel M; Higgins J; Visai L; Speziale P; Cox D; Foster TJ
Mol Microbiol; 2006 Jan; 59(1):212-30. PubMed ID: 16359330
[TBL] [Abstract][Full Text] [Related]
4. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
5. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.
Loughman A; Fitzgerald JR; Brennan MP; Higgins J; Downer R; Cox D; Foster TJ
Mol Microbiol; 2005 Aug; 57(3):804-18. PubMed ID: 16045623
[TBL] [Abstract][Full Text] [Related]
6. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets.
Niemann S; Spehr N; Van Aken H; Morgenstern E; Peters G; Herrmann M; Kehrel BE
Circulation; 2004 Jul; 110(2):193-200. PubMed ID: 15197141
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
9. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?
Kälvegren H; Majeed M; Bengtsson T
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1677-83. PubMed ID: 12842841
[TBL] [Abstract][Full Text] [Related]
11. The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.
Karczewski J; Connolly TM
Biochem Biophys Res Commun; 1997 Dec; 241(3):744-8. PubMed ID: 9434779
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.
Bayer AS; Sullam PM; Ramos M; Li C; Cheung AL; Yeaman MR
Infect Immun; 1995 Sep; 63(9):3634-41. PubMed ID: 7642301
[TBL] [Abstract][Full Text] [Related]
13. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
[TBL] [Abstract][Full Text] [Related]
14. Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B.
Miajlovic H; Loughman A; Brennan M; Cox D; Foster TJ
Infect Immun; 2007 Jul; 75(7):3335-43. PubMed ID: 17438032
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
16. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents.
Mondoro TH; Vostal JG
Platelets; 2002 Feb; 13(1):11-20. PubMed ID: 11918832
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
18. Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib.
Shenkman B; Rubinstein E; Dardik R; Tamarin I; Savion N; Varon D
Platelets; 1999; 10(1):36-44. PubMed ID: 16801069
[TBL] [Abstract][Full Text] [Related]
19. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
[TBL] [Abstract][Full Text] [Related]
20. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Mousa SA; Ahmad S
Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
